Market Talk
The stock market is a dicey proposition. Venture into it and dabble at your own risk. The Fed is sending signals that interest rates will come down, maybe around September. Generally, lowering interest rates are bullish for stocks.
On another note, your administration has opened the southern gates to millions. How will this affect the future economy and jobs and the growing deficit? Such and such remain to be seen, but the deficit is growing largely. Death and taxes, Ben reminded us of certainty.
Stock Talk
The following are few snip-it thoughts on a few stocks we watch.
Annovis Bio (ANVS): (update 07/11) After a nice run with early Parkinson's data , the stock is trading with volatility up and down in wide swings. On the bullish side, a drug that would be FDA approved to treat both Parkinson's and Alzheimer's with low side effects that happens with several present drugs by big pharmaceutical companies. But alas the bear case is that it will be more time before the FDA will take it all up with a meeting in October and it's already stated that an expanded Phase 3 trial is needed.
Speculation can only go so far before the short side steps in. It will ultimately be the FDA who will scrutinize scrubbed data closely and demand statistical significance in numbers of trial patients.
As a closing note on ANVS, let's just say the low float stock is very hard to predict as far as share price in the near and long term. So, lets refrain from trying here. On the other hand, it looks like a "swing stock" that is being traded heavily. As such it has the feel of a "pump n' dump" stock. As such it will not be mentioned here unless something of a real nature happens with ANVS going forward. If attempting the daytrading of ANVS, wish you more greens than reds and good luck. The volatility and price swings of ANVS can make one say- yikes! If in, it feels like a not too much stock due to more time needed and lack of sufficient cash to carry out the expensive areas needed. Anything can and will happen with ANVS stock.
Nvidia (NVDA) : After the 10 for 1 split many of us bought some NVDA. The initial reaction was for us "fomo" people to get in on the AI hoopla on the "cheap". But what happened? The ones that were in presplit like institutions, now have ten times more shares at one tenth the price. none the less, the institutions sold some of NVDA holdings. That affect may be wearing off now and NVDA is back to trading on fundamentals, yet still somewhat volatile. The near term still seems positive for NVDA from at least a few advantage points of AI leadership.
Intel (INTC) : From the 40's to the low 30's, Intel sank on lowered near term expectations due to investment in chip foundry manufacturing. However, Intel stands to be the ONLY semiconductor manufacturer in America. Perhaps, anybody that has been watching and reading notices that sentiment on INTC stock is turning from bearish to bullish? AMD and NVDA BOTH rely on Taiwan semiconductor to manufacture their chips. Do YOU see a possible issue there? Intel is set up to benefit from a new wave of AI personal computers coming as the masses upgrade. Yes, there is competition in the CPU market but Intel will remain a huge player in people buying up AI laptops at places like Best Buy and Walmart. More buyside analysts are turning to Intel while it's still in the 30's.
Devon Energy (DVN)
Good article relaying a Bank of America analyst recommending buy some DVN. Oil and Gold in America and Canada have a big future. Nobody except for Californian's, with moderate temps, want electric cars. They drop range by 40% in very cold weather. Want a heater on too? Forget about it! Good luck charging, stuck on the side of wintery road.
https://finance.yahoo.com/news/looking-bargains-bank-america-suggests-173649746.html
Kinross Gold (KGC): Long term? Oil and Gold in America and Canada have a big future. KGC covers the gold side from the mining position. KGC may require patience but looking for double digit share levels and a dividend too.
Vital Energy (VTLE) : Another growing Oil and gas company with acreage in oil rich basins in America. VTLE is a growth stock worthy of watching as the rich Arab sheiks try to play games on America and oil. The sheiks want to throw in with Russia and China? WE have some choice words for that!
Oncolytics Biotech (ONCY): A new trial started dosing in a Pancreatic Cancer study in Germany with that uses a combination of Pelarerep and a checkpoint inhibitor with or without a modified chemo. This is a long shot $1 buck stock at the moment. Pancreatic cancer is one tough cancer. This makes ONCY a spec stock with a "What if" ponderance. Some of us retail small investors think the evidence of the MoA to attack cancer with T fighter cells may result in a positive response. Yes, it's a hope and spec stock so we know - not too much. God bless the fighters that sign up to FIGHT.
For now, we close by noting that any view on the market and stocks on any particular day may change in the future days to come. That is why we watch and see how our views match up with the reality of the time. But trying to look ahead a few months into the future may be a way to do things. If you think too deep about world events and the recent alliances forming, projecting ahead can be a dicey endeavor. In all - we use the word maybe "some", not "too much" and play it accordingly. Remember never get arrogant in our various notions because things do change in the market and individual stocks are subject to many factors outside of our control.. So we try to -stay aware.
With all the above caveats and attempted prognostications, I will close this post. Stay tuned for more opining on the market and stocks to watch.
_____________
